Foscarnet Sodium Injection, Solution
Product Images NDC 43066-089

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Foscarnet Sodium (NDC 43066-089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Foscarnet Structural Formula (Image 01.jpg)

Chemical structure of foscarnet sodium showing its phosphate and carboxylate groups along with sodium ions and associated water molecules as represented in the molecular formula.*

FDA Label Image

Foscarnet Dosing Guide (Image 02)

A mathematical formula displays the calculation of creatinine clearance in mL/min/kg. It shows the equation for males as (140 - age) divided by (serum creatinine times 72), with a multiplication by 0.85 adjustment for females.*

FDA Label Image

Foscarnet Container Label 43066-089-10 (Image 03)

Foscarnet Sodium Injection 6000 mg per 250 mL (24 mg per mL) solution for intravenous use. The label includes usage instructions for central and peripheral intravenous infusion, storage conditions, and manufacturing details by Baxter Healthcare Corporation in Deerfield, IL, USA. The package volume is 250 mL.*

FDA Label Image

Foscarnet Carton Label 43066-089-10 1 Of 3 (Image 04)

FOSCARNET SODIUM 6000 mg per 250 mL (24 mg per mL) Sodium Injection label for intravenous use. The label includes storage instructions, single-dose usage, and administration precautions. It is manufactured for Baxter Healthcare Corporation and made in India. The product NDC is 43066-089-10.*

FDA Label Image

Foscarnet Carton Label 43066-089-10 2 Of 3 (Image 05)

Packaging label for Foscarnet Sodium Injection, 6000 mg per 250 mL (24 mg per mL) solution for intravenous use. The label indicates the product is for central intravenous infusion only and must be diluted for peripheral intravenous infusion. The labeler is Baxter Healthcare Corporation. The package contains 10 single-dose 250 mL bags.*

FDA Label Image

Foscarnet Carton Label 43066-089-10 3 Of 3 (Image 06)

Label for Foscarnet Sodium Injection 6,000 mg per 250 mL (24 mg/mL) intravenous solution by Baxter Healthcare Corporation. The label details product use for intravenous infusion, storage instructions, and preparation precautions. It includes a barcode, lot and expiration date area, and instructions for dilution and administration.*

FDA Label Image

Foscarnet Overpouch Label 43066-089-10 2 Of 2 (Image 07)

Label for Foscarnet Sodium Injection 6000 mg per 250 mL (24 mg/mL) intravenous solution by Baxter Healthcare Corporation. The label includes the product name prominently in white text on red background, dosage strength, NDC 43066-089-10, barcode, and usage instructions indicating central intravenous infusion only, with dilution required for peripheral intravenous infusion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.